Use of Cannabinoids in the treatment of degenerative skeletal muscle diseases; F.A. Iannotti, V. Di Marzo, K. Foster, C. Scott; WO2016059411A1 (PCT/GB2015/053044)
NUMERO BREVETTO: WO2016059411A1
INTERNATIONAL PUBLICATION NUMBER: WO2016059411A1
INTERNATIONAL APPLICATION NUMBER: PCT/GB2015/053044
The present invention relates to the use of cannabinoids in the treatment of degenerative skeletal muscle disease. In particular the degenerative skeletal muscle disease is Duchenne muscular dystrophy (DMD). Preferably the cannabinoids are one or more of: Cannabidiol (CBD); Cannabidivarin (CBDV); and Tetrahydrocannabivarin (THCV).
Area di ricerca: Salute e Benessere dell’uomo
Istituto di provenienza: Main Research Site, POZZUOLI (NA)